An interventional study of diagnostic strategy based on lung and cardiac ultrasonography in Dyspnea and Respiratory Distress Syndrome, sponsored by University Hospital, Toulouse. Recruiting at 1 site in France. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-12-04.
Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 124 studies in Dyspnea with a site in France — 33 open to participants now, 34 under way, none of them phase 3. Dyspnea · France.
Among the 124 studies in Dyspnea with a site in France, this one is the 10th largest by planned enrollment of the 66 interventional ones that give a count, is one of 10 that started in 2025, is one of 51 with no phase, reaches primary completion later than 20 of the 33 other live ones, and was the 103rd registered.
895 studies on the registry are indexed under Dyspnea; 189 are open to participants now.
Browse Dyspnea studies →33 of the 124 studies in Dyspnea with a site in France are open now. Recruiting first, the newest first:
Poitiers University Hospital · Sites in France
Ages 18+
Centre Hospitalier Universitaire de Nice · Sites in France
Ages 18+
Centre Hospitalier Universitaire, Amiens · Sites in France
Ages up to 1
Initiatives Bronchopneumopathie Chronique Obstructive (BPCO) · Sites in France
Ages 18+
Institut de Myologie, France · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 125 Dyspnea studies recruiting now, 68 (54%) set no upper age limit and 41 (33%) stop at 75 or younger; 18 take children under 18; 23 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
124 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 7 · Phase 3 7 · Phase 4 2
First in 2004; this study’s year is marked. 10 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 504 is above the median of 50 across 588 interventional studies indexed under Dyspnea.
Median enrollment 64 across the 66 interventional studies, 175 across the 58 observational. Of the 80 that completed or were terminated, 5 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 124 have an industry lead sponsor. The 10 most frequent:
University Hospital, Toulouse is the lead sponsor of 809 studies on the registry; 211 are open to participants now.
University Hospital, Toulouse has 5 studies filed under Dyspnea — fewer than ten, so there is no comparison to draw.
10 of the studies in Dyspnea with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05103670University Hospital, BrestVentilation/Perfusion PET/CT With Galligas and 68Ga-MAA for Regional Lung Function Assessment After Pulmonary Embolism | 2026-12-22 |
| NCT05015153University Hospital, BrestImpact on Quality of Life With Pulmonary RehAbilitation After Pulmonary eMBOlism: RAMBO Study | 2027-02-25 |
| NCT06867354Assistance Publique - Hôpitaux de ParisPrevalence, Determinants and Consequences of Dyspnea During Weaning in Critically Ill Obese Patients | 2027-03 |
| NCT07835945Centre Hospitalier Universitaire de NiceComparison of Arterial and Capillary Blood Gas Analyses in Patients With Respiratory Distress Due to COPD or APE | 2027-03-24 |
| NCT07445750Assistance Publique - Hôpitaux de ParisSports Shoes and the Six-Minute Walk Test in COPD | 2027-04-01 |
Add all 10 to your calendar (.ics) → With an account.
Among the 124 studies in Dyspnea with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Prospective trial to evaluate the impact on the initial therapeutic inadequacy of a management strategy for acute dyspnea in the elderly based on the use of lung and cardiac ultrasonography.
Acute dyspnea is a frequent and serious reason of admission in Emergency Department (ED), with a one-month mortality close to 16%. It is difficult to diagnose in the initial assessment phase since the cause of this symptom can vary (cardiological, pulmonary, infectious, etc.) and the symptoms can be misleading. This difficulty in diagnosing delays the implementation of appropriate therapeutic management even as the timeliness of management is associated with a reduction in mortality. These issues are particularly important in the elderly.
Lung and cardiac ultrasonography performed by the emergency physician, immediately available at the patient's bedside, could reduce the diagnostic and therefore therapeutic delay.
However, the impact of a diagnostic strategy based on lung and cardiac ultrasonography in dyspneic elderly subjects has not been evaluated.
Patients will be randomized in two groups : "standard of care" or "clinical ultrasound" group. Treatments initiated in Emergency Department (ED) will be noted to be compared to final diagnosis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Eligible patients will be aged over 65 years, affiliated with the French social security system, and presenting to the ED with acute dyspnea (onset \<14 days) accompanied by severity signs before or at triage (respiratory rate ≥22 and SpO2 \<92% on room air). The enrolling emergency physician (EP) must be the patient's treating physician and must be trained in LuCUS. Written from the patient or their legal representative is required for inclusion
Exclusion Criteria:
dyspnea secondary to thoracic trauma, dyspnea clearly related to COVID-19, known pulmonary fibrosis or lung cancer, prior administration of specific treatment for dyspnea before inclusion, immediate need for endotracheal intubation, patients identified as being at end-of-life, and individuals under legal guardianship or deprived of liberty.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
diagnostic strategy based on the protocolized implementation of clinical lung and cardiac ultrasonography, with a proposed diagnostic and therapeutic focus based on the results.
Diagnostic Test: diagnostic strategy based on lung and cardiac ultrasonography
diagnostic and therapeutic strategy based on the usual practices of the department and the clinician
cardiopulmonary ultrasound performed by the emergency physician, immediately at patient's bed
therapeutic inadequacy
therapeutic inadequacy between initiated emergency treatments and the final diagnosis made by expert opinion
Time frame: Hour 1
correct diagnosis
correct diagnosis at the emergency department discharge (compared with final diagnosis made by expert opinion)
Time frame: emergency department discharge (up to hour 4)
duration of emergency department stay
duration in emergency department (in hours)
Time frame: emergency department discharge (up to hour 4)
Post-emergency hospital stay
duration in Post-emergency hospital department: in medicine/surgery/obstetrics or follow-up and rehabilitation care (in days)
Time frame: Day 30
Number of days alive outside hospital between D0 and D30
Number of days alive outside hospital between D0 and D30
Time frame: Day 30
Care cost
Care cost - Direct and indirect medical cost looking at French social security spendings for patients
Time frame: Day 30
Plan to share: No
Started Nov 2025 (actual). Primary completion is estimated for May 2027, 17 months after the start.
Of 268 non-industry interventional studies with no phase under Dyspnea, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 28. This study's planned 17 months is above that.
Counting every sponsor, half of 284 studies reached it within 13 months; a quarter within 6 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Toulouse →